Here are two alternative stocks riding the GLP-1 weight loss trend
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications designed to mimic the bodys natural GLP-1 hormone
Testing for the Drug If you ever suspect someone has given you this drug without your knowledge, it is best to get tested immediately
Why the FDA Issued Warnings The FDA determined that companies marketing compounded retatrutide: Sold an unapproved new drug without FDA authorization Misbranded products by providing no adequate directions for safe use Improperly claimed compounding exemptions that do not apply to investigational substances In short, these products are not permitted for compounding or distribution under current federal law
GLP-1 drugs, short for glucagon-like peptide-1 receptor agonists, have emerged as a valuable tool in diabetes and weight management
There are no residual fees, no locked-in contracts, and no membership charges continuing in the background